AstraZeneca raising profile in Bay Area

AstraZeneca announced Wednesday morning that it has opened a new facility in South San Francisco, at the Cove at Oyster Point. The facility will combine Bay Area employees from Acerta Pharma, MedImmune, Pearl Therapeutics and AstraZeneca’s TIDE (Technology Innovation & Delivery Excellence) group.